Neurology, Vol. 65

  • Sep. 2005, Neurology, Vol. 65, Issue 6, Pages 812-819

    David J. Rog, PhD, from the Walton Centre for Neurology and Neurosurgery at the University of Liverpool, et al., wrote in a Sep. 2005 article titled “Randomized, Controlled Trial of Cannabis-Based Medicine in Central Pain in Multiple Sclerosis” in the journal Neurology:

    “BACKGROUND: Central pain in multiple sclerosis (MS) is common and often refractory to treatment…

    CONCLUSIONS: Cannabis-based medicine is effective in reducing pain and sleep disturbance in patients with multiple sclerosis related central neuropathic pain and is mostly well tolerated.”

  • Tags: , ,
  • Comments